Xeno Diagnostics, was originally established as an independent research laboratory in 2007. Xeno became an accredited high-complexity CLIA lab in order to process clinical specimens both for routine clinical work, but also to support later phase clinical trials. 

Xeno’s CLIA certification is accredited through the Commission of Office Laboratory Accreditation (COLA). On five of six inspections, Xeno has received COLA’s Laboratory Excellence Award as no deficiencies were found on those inspections. 

To meet the needs of our clients in drug and device development, Xeno Diagnostics is also a GLP compliant laboratory, in accordance with 21 CFR part 58. Learn more about our regulatory compliance here.